Form 4 for LXRX LEXICON PHARMACEUTICALS, INC.
Accepted 2026-02-25 00:00:00 ET · period of report 2026-02-23 · accession 0001062822-26-000032 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-25 | 2026-02-23 | LXRX | DEBBANE RAYMOND | Dir | P - Purchase | $1.47 | +100.0K | 1.90M | +6% | +$147.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-23 | P | A | 100,000 | $1.47 | 1,904,186 | D | — | — |